课题基金 / 基金详情

Pathologic and biologic study of extranodal lymphomas for the clarification of its molecular pathogenesis

Pathologic and biologic study of extranodal lymphomas for the clarification of its molecular pathogenesis
结外淋巴瘤的病理和生物学研究以阐明其分子发病机制
批准号:
10670188
负责人:
NAKAMURA Shigeo
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

NAKAMURA Shigeo的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In a recent year, much interest is focused on the biologic behavior of extranodal lymphomas, especially of mucosa-associated lymphoid tissue (MALT) type. The t(11;18)(q21;q21) translocation is a characteristic chromosomal aberration in low-grade B-cell lymphoma of MALT type. We have identified a YAC clone y789F3, which includes the breakpoint at 18q21 in a MALT lymphoma patient. BAC and PAC contigs were constructed on the YAC, and BAC 193f9 was found to encompass the breakpoint region. We further narrowed down the breakpoint region at 18q21 in five MALT lymphoma patients by means of FISH and Southern blot analyses using the plasmid contig constructed from BAC193f9. The breakpoints at 18q21 in three of the five MALT lymphoma patients were found to be clustered approximately within the 20kb region. By using exon amplification and cDNA library screening, we identified a novel cDNA spanning the breakpoint region that exhibited aberrant mRNA signals in four of the five MALT lymphoma patients. The nucleotide sequence predicted an 813 amino acid protein that shows significant sequence similarity to the CD22β and laminin 5 α3b subunit. We refereed to the gene encoding this transcript as MALT1. The alteration of MALT1 by translocation strongly suggested that this gene plays an important role in the pathogenesis of MALT lymphoma. Notably, among them, MALT lymphoma with API2-MALT1 gene expression appeared to constitute a homogeneous disease entity. The microscopic appearance is distinctive enough for the diagnosis to be made or at least entertained in routine sections. Their anatomical sites also preferred to lung, intestine, and less commonly stomach. In addition, gastric MALT lymphoma with the genetic alteration of API2-MALT1 seemed to have no relationship with Helicobacter pylori infection. The presence of this set of features in this distinctive tumors has not been sufficiently emphasized in previous reports.
期刊论文(102)
专著(0)
科研奖励(0)
会议论文
Suzuki R, et al.: "Idiopathic eosinophilia and adult T-cell leukemia"N Engl J Med. 342. 660 (2000)
Suzuki R 等人:“特发性嗜酸性粒细胞增多症和成人 T 细胞白血病”N Engl J Med。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakamura S, et al.: "Iodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker : a clinico-"Am J Surg Pathol. 23. 363-376 (1999)
Nakamura S 等人:“表达滤泡树突状细胞标记物 CD21 而没有任何其他 B 细胞标记物的碘奇金病:临床”Am J Surg Pathol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Suzuki R, et al.: "Importance of T-cell receptor delta-chain gene analysis on CD7+ and CD56+ myeloid/NK cell precursor acute leukemia"Blood. 91. 2623-2624 (1998)
Suzuki R 等人:“T 细胞受体 δ 链基因分析对 CD7 和 CD56 骨髓/NK 细胞前体急性白血病的重要性”血液。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Suzuki R, et al.: "Selective usage of D-type cyclins in lymphoid malignancies."Leukemia. 13. 1335-1342 (1999)
Suzuki R 等人:“D 型细胞周期蛋白在淋巴恶性肿瘤中的选择性使用。”白血病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
80
    Clinicopathologic and biologic study oriented for the new classification of EBV-associated lymphoproliferative disorder
    • 批准号:
      19590344
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2007
    • 负责人:
      NAKAMURA Shigeo
    • 依托单位:
    Clinicopathologic and molecular biological study of senile/age-related EBV-associated B-cell
    Clinicopathologic and molecular biologic analyses for recognizing newly-defined adult lymphoma entities.
    • 批准号:
      14570175
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      NAKAMURA Shigeo
    • 依托单位:
    悪性リンパ腫におけるMALT1とAPI2遺伝子発現の意義の病理学的、生物学的研究
    • 批准号:
      12670191
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2000
    • 负责人:
      NAKAMURA Shigeo
    • 依托单位: